EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Evaluation of 1,2,3‐Triazole‐Quinazolinone Derivatives as Promising α‐Glucosidase Inhibitors with Favorable Drug‐Like Properties

Teesuda Sirichai, Suwanan Uipanit, Suparerk Borwornpinyo, Kamonwan Jaitham, Phichachat Nititrirongkul, Weerasak Songoen, Boonsong Kongkathip, Wanchai Pluempanupat, Paiboon Ngernmeesri, Nutthawat Chuanopparat iD

Chemistry – An Asian Journal · 2025

DOI: 10.1002/asia.70365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Teesuda Sirichai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Advanced Magnetic Resonance (AMR), Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsa…. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Quinazolinones, Triazoles, alpha-Glucosidases. Die Arbeit nennt 59 Literaturangaben. Gefördert von: the Center of Excellence for Innovation in Chemistry, Kasetsart University Research and Development Institute (KURDI), the Graduate School, Kasetsart University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to design and synthesize a series of 1,2,3‐triazole‐quinazolinone derivatives ( 8a – 8q ) as potential α‐glucosidase inhibitors. Our initial model compound 8a exhibited higher in vitro α‐glucosidase inhibitory activity (IC 50 = 10.16 ± 0.358 µM) compared to acarbose (IC 50 = 51.23 ± 10.21 µM). This promising result was supported by molecular docking studies, which revealed favorable binding interactions with human α‐glucosidase, with an estimated binding free energy of –6.93 kcal/mol and a predicted inhibition constant ( K ᵢ) of 8.27 µM. Based on the promising in vitro and in silico results of 8a , the other sixteen 1,2,3‐triazole‐quinazolinone derivatives ( 8b – 8q ) were subsequently synthesized. Screening identified nine compounds with over 70% inhibition, with compound 8d emerging as the most potent (IC 50 of 1.72 ± 0.046 µM). Docking studies of 8d with both Saccharomyces cerevisiae and human α‐glucosidase showed strong interactions, consistent with experimental findings. Structure‐activity relationship (SAR) analysis analysis suggested that the quinazolinone core, 1,2,3‐triazole ring, amino sulfide moiety, and a benzyl group with an ortho or meta halogen (Br or I) are crucial for optimal activity. Furthermore, 8d passed ADMET predictions, suggesting it could be a promising orally bioavailable inhibitor. These findings provide valuable insights for developing new α‐glucosidase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase InhibitorsQuinazolinonesTriazolesalpha-GlucosidasesDrug DesignHumansStructure-Activity RelationshipMolecular Docking SimulationSaccharomyces cerevisiaeMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

1,2,3‐triazoleAnti‐diabetic agentsClick reactionQuinazolinoneα‐glucosidase inhibitor

Substanzen

Glycoside Hydrolase InhibitorsQuinazolinonesTriazolesalpha-Glucosidases

Autor:innen und Institutionen

  • Unit for Advanced Magnetic Resonance (AMR), Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, 50 Ladyao Road, Chatuchak District, Bangkok, 10900, Tha…
  • Excellent Center for Drug Discovery, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
  • Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
  • Central Laboratory and Greenhouse Complex, Research and Academic, Service Center, Faculty of Agriculture at Kamphaeng Saen, Kasetsart University, Kamphaeng Sean Campus, Nakhon Pathom, 73140, Thailand.

ORCID-Profile: Nutthawat Chuanopparat

Förderung

  • the Center of Excellence for Innovation in Chemistry
  • Kasetsart University Research and Development Institute (KURDI)
  • the Graduate School, Kasetsart University
  • the Royal Golden Jubilee Ph.D. (RGJ-PHD) Program
  • Faculty of Science, Kasetsart University

Zitieren

APA

Sirichai, T., Uipanit, S., Borwornpinyo, S., Jaitham, K., Nititrirongkul, P., Songoen, W., Kongkathip, B., Pluempanupat, W., Ngernmeesri, P., & Chuanopparat, N. (2025). Design, Synthesis, and Biological Evaluation of 1,2,3‐Triazole‐Quinazolinone Derivatives as Promising α‐Glucosidase Inhibitors with Favorable Drug‐Like Properties. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.70365

Vancouver

Sirichai T, Uipanit S, Borwornpinyo S, Jaitham K, Nititrirongkul P, Songoen W, et al. Design, Synthesis, and Biological Evaluation of 1,2,3‐Triazole‐Quinazolinone Derivatives as Promising α‐Glucosidase Inhibitors with Favorable Drug‐Like Properties. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.70365

BibTeX
@article{Sirichai2025,
  author = {Sirichai, Teesuda and Uipanit, Suwanan and Borwornpinyo, Suparerk and Jaitham, Kamonwan and Nititrirongkul, Phichachat and Songoen, Weerasak and Kongkathip, Boonsong and Pluempanupat, Wanchai and Ngernmeesri, Paiboon and Chuanopparat, Nutthawat},
  title = {Design, Synthesis, and Biological Evaluation of 1,2,3‐Triazole‐Quinazolinone Derivatives as Promising α‐Glucosidase Inhibitors with Favorable Drug‐Like Properties},
  journal = {Chemistry – An Asian Journal},
  year = {2025},
  doi = {10.1002/asia.70365}
}
Kostenlos starten →